Cargando…
Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial
BACKGROUND: Effective treatment for Coronavirus Disease-2019 (COVID-19) is under intensive research. Nigella sativa oil (NSO) is a herbal medicine with antiviral and immunomodulatory activities, and has been recommended for the treatment of COVID-19. This study aimed to evaluate the efficacy of NSO...
Autores principales: | Koshak, Abdulrahman E., Koshak, Emad A., Mobeireek, Abdullah F., Badawi, Mazen A., Wali, Siraj O., Malibary, Husam M., Atwah, Ali F., Alhamdan, Meshari M., Almalki, Reem A., Madani, Tariq A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364675/ https://www.ncbi.nlm.nih.gov/pubmed/34407441 http://dx.doi.org/10.1016/j.ctim.2021.102769 |
Ejemplares similares
-
Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial
por: Koshak, Abdulrahman, et al.
Publicado: (2021) -
Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial
por: Koshak, Abdulrahman E., et al.
Publicado: (2020) -
Medicinal benefits of Nigella sativa in bronchial asthma: A literature review
por: Koshak, Abdulrahman, et al.
Publicado: (2017) -
Nigella sativa L as a potential phytotherapy for coronavirus disease 2019: A mini review of in silico studies
por: Koshak, Dr Abdulrahman E., et al.
Publicado: (2020) -
Comparative Immunomodulatory Activity of Nigella sativa L. Preparations on Proinflammatory Mediators: A Focus on Asthma
por: Koshak, Abdulrahman E., et al.
Publicado: (2018)